Research Highlights Link Between Smell Loss and Alzheimer’s Disease

A decreased ability to smell might serve as an early indicator of Alzheimer’s disease, and recent studies clarify why that could be the case. Researchers found that microglia—immune cells in the brain—mistakenly eliminate nerve connections between the locus coeruleus and the olfactory bulb, both of which are essential for encoding smells.

This immune response occurs when overactive neurons present weird changes in their membranes, leading microglia to falsely identify these nerve fibers as damaged. By uncovering this process, the research suggests a potential path for diagnosing and treating Alzheimer’s before cognitive symptoms kick in.

Key Findings

• Immune Misfire: Microglia dismantle nerve fibers connecting the olfactory bulb and locus coeruleus.
• Early Signal: These modifications happen prior to noticeable cognitive decline, suggesting smell loss could be a diagnostic marker.
• Therapeutic Window: The findings might allow for earlier application of amyloid-beta antibody therapies.

Loss of smell can indeed be one of the first signs of Alzheimer’s disease, often preceding more obvious cognitive issues. This study from DZNE and Ludwig-Maximilians-Universität München (LMU) identifies a crucial role for the brain’s immune response, which appears to indiscriminately attack the nerve fibers important for recognizing odors.

Published in the journal Nature Communications, this research involved both mouse and human samples, including brain tissue analyses and PET scans. These insights could lead to new methods for early diagnosis and treatment approaches.

Researchers have discovered that the olfactory dysfunction stems from microglia eliminating connections between the olfactory bulb, responsible for processing smells, and the locus coeruleus, important for regulating sensory information among other physiological processes, including blood flow and sleep-wake cycles.

Dr. Lars Paeger from DZNE and LMU explains, “In early Alzheimer’s disease, we see these changes in nerve fibers linking the two regions. This leads to microglial activity that breaks them down under the false impression that they are defective.”

In particular, the team noted alterations in the membranes of these nerve fibers. Usually, phosphatidylserine, a fatty acid, is found inside neuron membranes, but in this case, it’s been displaced to the exterior. “This shift is seen as a signal for microglia to clear out the affected neurons, a process typically employed in synaptic pruning to remove unnecessary connections,” says Paeger.

These findings are underpinned by extensive observations, including studies on Alzheimer’s-like mice, the analysis of brain samples from deceased patients, and PET scans of living individuals showing mild cognitive impairment or early Alzheimer’s.

While the link between smell issues and nerve damage has been noted in discussions about Alzheimer’s, the underlying causes remained obscure until now. “We highlight an immunological mechanism behind such dysfunction—crucially, these events occur even in the early stages of the disease,” notes Joachim Herms, a research leader at DZNE and LMU.

Prospects for Early Diagnosis

New treatments, specifically amyloid-beta antibodies, have emerged to combat Alzheimer’s, and revealing this connection could be pivotal. If applied early enough, this therapy may yield better results.

“Our research may facilitate the identification of individuals at risk of developing Alzheimer’s, allowing them to undergo thorough testing before cognitive issues surface. This could lead to timely intervention with these antibodies, potentially improving their outcomes,” Herms adds.